Literature DB >> 12644733

Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up.

Franziska Güttinger1, Patrick Gschwend, Bernd Schulte, Jürgen Rehm, Ambros Uchtenhagen.   

Abstract

Since January 1994, heroin-assisted treatment for opiate addicts has been available in Switzerland. This is the first report of the long-term effects of this form of treatment. The report examines subjects who entered a study involving medical prescription of opiates (Projekt zur ärztlichen Verschreibung von Betäubungsmitteln; PROVE) in Switzerland between January 1994 and March 1995 (n = 366). Opiates were dispensed in eight treatment centres. A follow-up was conducted 6 years after treatment entry. Two groups were assessed: clients who have continuously been on heroin-assisted treatment since entry into the PROVE study or who re-entered this treatment, and ex-clients who had discontinued heroin-assisted treatment at the time of follow-up. Two kinds of comparisons were conducted. Firstly, conditions at treatment entry were compared to 6-year follow-up outcomes, and secondly, outcomes were compared between clients still on heroin-assisted treatment and those who had been discharged. It was found that 46% of the clients still alive were on heroin-assisted treatment at the time of follow-up. A comparison of the present living conditions showed very little difference between those in treatment and those who had terminated treatment. Compared to the situation at entry, the results of the follow-up showed a significant decrease in the use of illegal substances, illegal income and most other variables concerning social conditions, but they also showed an increase in unemployment and reliance on social benefits. Heroin-assisted treatment is thus efficacious in the long-term course of treatment and is still effective after termination of treatment with respect to living conditions and use of illicit substances. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644733     DOI: 10.1159/000068811

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  16 in total

Review 1.  Retention in medication-assisted treatment for opiate dependence: A systematic review.

Authors:  Christine Timko; Nicole R Schultz; Michael A Cucciare; Lisa Vittorio; Christina Garrison-Diehn
Journal:  J Addict Dis       Date:  2015-10-14

Review 2.  Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.

Authors:  Benedikt Fischer; Eugenia Oviedo-Joekes; Peter Blanken; Christian Haasen; Jürgen Rehm; Martin T Schechter; John Strang; Wim van den Brink
Journal:  J Urban Health       Date:  2007-07       Impact factor: 3.671

Review 3.  Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.

Authors:  James Bell; Vendula Belackova; Nicholas Lintzeris
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

4.  Opiate-addicted parents in methadone treatment: long-term recovery, health, and family relationships.

Authors:  Martie L Skinner; Kevin P Haggerty; Charles B Fleming; Richard F Catalano; Randy R Gainey
Journal:  J Addict Dis       Date:  2011-01

Review 5.  Prescription of heroin for the management of heroin dependence: current status.

Authors:  Nicholas Lintzeris
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; Suzanne Brissette; Jill Chettiar; Pascal Schneeberger; David C Marsh; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  J Urban Health       Date:  2008-08-29       Impact factor: 3.671

7.  Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; David C Marsh; Daphne Guh; Suzanne Brissette; Candice Gartry; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  Clin Trials       Date:  2009-06       Impact factor: 2.486

Review 8.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

9.  Efficacy of prescribed injectable diacetylmorphine in the Andalusian trial: Bayesian analysis of responders and non-responders according to a multi domain outcome index.

Authors:  Emilio Perea-Milla; Luis Carlos Silva Ayçaguer; Joan Carles March Cerdà; Francisco González Saiz; Francisco Rivas-Ruiz; Alina Danet; Manuel Romero Vallecillo; Eugenia Oviedo-Joekes
Journal:  Trials       Date:  2009-08-14       Impact factor: 2.279

10.  NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America.

Authors:  Candice C Gartry; Eugenia Oviedo-Joekes; Nancy Laliberté; Martin T Schechter
Journal:  Harm Reduct J       Date:  2009-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.